Name: Yasmin / Yaz
Manufacturer: Bayer AG
Date approved: 2001
Approved uses: Contraception, Premenstrual Dysphoric Disorder
Off-Label uses: Acne
• Gallbladder Disease
• Deep Vein Thrombosis
• Pulmonary Embolism
• Sudden Death
Common Misspellings: Yazmin, Yasmen, Yasmine
Yasmin (also known as Yaz/drospirenone/ethinyl Estradiol. Generic : Ocella) is a birth control pill developed and manufactured by Bayer, AG. The medicine works by disrupting a woman’s natural menstrual cycle and providing a daily dose of hormones to regulate a new menstrual cycle. Bayer AG has been involved in a few discussions with the Food and Drug Administration over questionable advertising campaigns seeming to suggest that Yasmin/Yaz has less side effects than other contraceptive medications. Recent reports indicate that dangerous side effects could occur in women with preexisting conditions such as high blood pressure, diabetes, or obesity.
Close to 25,000 Yasmin & Yaz Lawsuits filed in East St. Louis
Pre-Trial Hearings Commence
Close to 25,000 contraceptive lawsuits were filed against Bayer Corp., the maker of the birth control Yaz and Yasmin in a federal courthouse in East St. Louis, the hometown of the pharmaceutical company.
The pre-trial proceedings include lawsuits from women across the country alleging the pill causes an increased rick for strokes, heart attacks, pulmonary embolism, thrombosis, cardiac arrhythmia, gallbladder disease, kidney failure and sudden death. Although many of these side effects are risks associated with other birth control pills, they have occurred at a substantially higher rate among women who were taking Yaz, Yasmin or the generic version of the drug, Ocella, compared to women who took other forms of the pill.
Unlike other pills currently on the market, Yaz combines a common oral contraceptive ingredient, ethinyl estradiol, with dropspirenone, a synthetic progesterone hormone. The combination has been marketed by Bayer as the only pill capable of controlling anger, irritability, bloating, depression, muscle aches and headaches associated with premenstrual dysphoric disorder.
The outcome of the Yasmin litigation may be used as a guideline for future Yasmin and Yaz lawsuits.
Quality Legal Advice from LegalView
Many of those who have been harmed by the side effects of Yasmin can discuss the possibility of legal recourse to gain potential monetary compensation for the pain and suffering they have endured. Oftentimes, out-of-pocket diagnostic procedures or additional medical complications can create an undue financial hardship on the individual. Many women have considered contacting a Yasmin attorney for additional legal counsel about the harmful drug.
FDA’s Yasmin Hearing Faces Conflict of Interest
The FDA seemed on the right track by requesting a hearing to investigate the safety and effectiveness of the birth control pill Yasmin, also known as Yaz or Ocella. The advisors ruled that the benefits of the popular medication far outweigh the risks of blood clots.
However, the FDA didn’t disclose that three of the advisers had ties to Bayer, the manufacturer of the drug. Because of this, many women who have filed lawsuits against the company have asked U.S. District Judge David Herndon to review the potential conflict of interest.
In a close 15-11 vote, the panel chose to keep Yasmin, Yaz and other drospirenone containing oral contraceptives on the market or issue a black box warning, the most severe warning the FDA can impose on medication.
Although the FDA reminded participants that they would be held to the same conflict of interest standards and laws as FDA employees, the creditentials of three members seemed to exclude vital information about their connections to Bayer.
The connections may make it difficult for them to make an impartial decision. Former FDA Commissioner David Kessler stated that in his opinion, “the FDA advisory committee was not independent of Bayer, and its recommendations and votes need to be viewed as such.”
Yaz, Yasmin and Ocella have been linked to serious cardiovascular complications, including deep vein thrombosis, pulmonary embolisms, stroke and gall bladder damage.